National Health Investors (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments.

It is set to report its Q1 2025 earnings on May 5. Wall Street analysts expect the company to post EPS of $1.13, up from $1.12 in the prior-year period. According to Benzinga Pro, quarterly revenue is expected to reach $85.13 million, up from $81.51 million a year earlier.

Don't Miss:

• Inspired by Uber and Airbnb – Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets – with $1,000 you can invest at just $0.26/share!
• Hasbro, MGM, and Skechers trust this AI marketing firm — invest pre-IPO from $0.55 per share now.

If You Bought National Health Investors Stock 10 Years Ago

The company's stock traded at approximately $70.66 per share 10 years ago. If you had invested $10,000, you could have bought roughly 142 shares. Currently, shares trade at $70.20, meaning your investment's value could have declined to $9,935 from stock price depreciation. However, National Health Investors also paid dividends during these 10 years. 

National Health Investors' dividend yield is currently 5.04%. Over the last 10 years, it has paid about $38.91 in dividends per share, which means you could have made $5,507 from dividends alone. 

Summing up $9,935 and $5,507, we end up with the final value of your investment, which is $15,442. This is how much you could have made if you had invested $10,000 in National Health Investors stock 10 years ago. This means a total return of 54.42%. However, this figure is significantly less than the S&P 500 total return for the same period, which was 193.10%.

Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — this is your last chance to become an investor for $0.80 per share.

What Could The Next 10 Years Bring? 

National Health Investors has a consensus rating of "Hold" and a price target of $68 based on the ratings of 14 analysts. The price target implies a more than 3% potential downside from the current stock price.

On Feb. 25, the company announced its Q4 2024 earnings, posting FFO of $1.12, compared to the consensus of $1.11, and revenues of $85.75 million, compared to the consensus of $82.67 million, as reported by Benzinga.

“The fourth quarter results exceeded our internal expectations as fundamentals remain strong throughout the portfolio with continued improvement in EBITDARM coverage trends, year-over-year cash rental income growth of 8.6%, SHOP NOI growth of 12.5%, and positive contributions from acquisitions completed during the year,” said CEO Eric Mendelsohn.

See Also: If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it?

The company provided its full-year 2025 guidance, expecting normalized FFO attributable to common stockholders in the range of $214.7 million to $218.1 million.

Given the expected downside potential, growth-focused investors may not find National Health Investors stock attractive. Conversely, the stock can be a good option for income-focused investors, who can benefit from the company's solid dividend yield of 5.04%.

Check out this article by Benzinga for three more stocks offering high dividend yields.

Read Next:

• Invest in the Future of Digital Engagement. Own a Piece of the $100 Billion Metaverse Today for Just $500.
• Deloitte's fastest-growing software company partners with Amazon, Walmart & Target – Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!

National Health Investors (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments.

It is set to report its Q1 2025 earnings on May 5. Wall Street analysts expect the company to post EPS of $1.13, up from $1.12 in the prior-year period. According to Benzinga Pro, quarterly revenue is expected to reach $85.13 million, up from $81.51 million a year earlier.

Don't Miss:

• Inspired by Uber and Airbnb – Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets – with $1,000 you can invest at just $0.26/share!
• Hasbro, MGM, and Skechers trust this AI marketing firm — invest pre-IPO from $0.55 per share now.

If You Bought National Health Investors Stock 10 Years Ago

The company's stock traded at approximately $70.66 per share 10 years ago. If you had invested $10,000, you could have bought roughly 142 shares. Currently, shares trade at $70.20, meaning your investment's value could have declined to $9,935 from stock price depreciation. However, National Health Investors also paid dividends during these 10 years. 

National Health Investors' dividend yield is currently 5.04%. Over the last 10 years, it has paid about $38.91 in dividends per share, which means you could have made $5,507 from dividends alone. 

Summing up $9,935 and $5,507, we end up with the final value of your investment, which is $15,442. This is how much you could have made if you had invested $10,000 in National Health Investors stock 10 years ago. This means a total return of 54.42%. However, this figure is significantly less than the S&P 500 total return for the same period, which was 193.10%.

Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — this is your last chance to become an investor for $0.80 per share.

What Could The Next 10 Years Bring? 

National Health Investors has a consensus rating of "Hold" and a price target of $68 based on the ratings of 14 analysts. The price target implies a more than 3% potential downside from the current stock price.

On Feb. 25, the company announced its Q4 2024 earnings, posting FFO of $1.12, compared to the consensus of $1.11, and revenues of $85.75 million, compared to the consensus of $82.67 million, as reported by Benzinga.

“The fourth quarter results exceeded our internal expectations as fundamentals remain strong throughout the portfolio with continued improvement in EBITDARM coverage trends, year-over-year cash rental income growth of 8.6%, SHOP NOI growth of 12.5%, and positive contributions from acquisitions completed during the year,” said CEO Eric Mendelsohn.

See Also: If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it?

The company provided its full-year 2025 guidance, expecting normalized FFO attributable to common stockholders in the range of $214.7 million to $218.1 million.

Given the expected downside potential, growth-focused investors may not find National Health Investors stock attractive. Conversely, the stock can be a good option for income-focused investors, who can benefit from the company's solid dividend yield of 5.04%.

Check out this article by Benzinga for three more stocks offering high dividend yields.

Read Next:

• Invest in the Future of Digital Engagement. Own a Piece of the $100 Billion Metaverse Today for Just $500.
• Deloitte's fastest-growing software company partners with Amazon, Walmart & Target – Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!

UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets.

Get the latest stock analysis from Benzinga?

• NATIONAL HEALTH INVESTORS (NHI): Free Stock Analysis Report

This article If You Invested $10K In National Health Investors Stock 10 Years Ago, How Much Would You Have Now? originally appeared on Benzinga.com

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.